These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 23575223)

  • 1. Activation of p38 signaling increases utrophin A expression in skeletal muscle via the RNA-binding protein KSRP and inhibition of AU-rich element-mediated mRNA decay: implications for novel DMD therapeutics.
    Amirouche A; Tadesse H; Lunde JA; Bélanger G; Côté J; Jasmin BJ
    Hum Mol Genet; 2013 Aug; 22(15):3093-111. PubMed ID: 23575223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinatorial therapeutic activation with heparin and AICAR stimulates additive effects on utrophin A expression in dystrophic muscles.
    Péladeau C; Ahmed A; Amirouche A; Crawford Parks TE; Bronicki LM; Ljubicic V; Renaud JM; Jasmin BJ
    Hum Mol Genet; 2016 Jan; 25(1):24-43. PubMed ID: 26494902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Converging pathways involving microRNA-206 and the RNA-binding protein KSRP control post-transcriptionally utrophin A expression in skeletal muscle.
    Amirouche A; Tadesse H; Miura P; Bélanger G; Lunde JA; Côté J; Jasmin BJ
    Nucleic Acids Res; 2014 Apr; 42(6):3982-97. PubMed ID: 24371285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological activation of PPARbeta/delta stimulates utrophin A expression in skeletal muscle fibers and restores sarcolemmal integrity in mature mdx mice.
    Miura P; Chakkalakal JV; Boudreault L; Bélanger G; Hébert RL; Renaud JM; Jasmin BJ
    Hum Mol Genet; 2009 Dec; 18(23):4640-9. PubMed ID: 19744959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Celecoxib treatment improves muscle function in mdx mice and increases utrophin A expression.
    Péladeau C; Adam NJ; Jasmin BJ
    FASEB J; 2018 Sep; 32(9):5090-5103. PubMed ID: 29723037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of FHL1 as a therapeutic target for Duchenne muscular dystrophy.
    D'Arcy CE; Feeney SJ; McLean CA; Gehrig SM; Lynch GS; Smith JE; Cowling BS; Mitchell CA; McGrath MJ
    Hum Mol Genet; 2014 Feb; 23(3):618-36. PubMed ID: 24087791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise increases utrophin protein expression in the mdx mouse model of Duchenne muscular dystrophy.
    Gordon BS; Lowe DA; Kostek MC
    Muscle Nerve; 2014 Jun; 49(6):915-8. PubMed ID: 24375286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin increases peroxisome proliferator-activated receptor γ Co-activator-1α and utrophin a expression in dystrophic skeletal muscle.
    Ljubicic V; Jasmin BJ
    Muscle Nerve; 2015 Jul; 52(1):139-42. PubMed ID: 25908446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PMO-based let-7c site blocking oligonucleotide (SBO) mediated utrophin upregulation in mdx mice, a therapeutic approach for Duchenne muscular dystrophy (DMD).
    Sengupta K; Loro E; Khurana TS
    Sci Rep; 2020 Dec; 10(1):21492. PubMed ID: 33298994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol decreases inflammation and increases utrophin gene expression in the mdx mouse model of Duchenne muscular dystrophy.
    Gordon BS; Delgado Díaz DC; Kostek MC
    Clin Nutr; 2013 Feb; 32(1):104-11. PubMed ID: 22795790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The utrophin promoter A drives high expression of the transgenic LacZ gene in liver, testis, colon, submandibular gland, and small intestine.
    Takahashi J; Itoh Y; Fujimori K; Imamura M; Wakayama Y; Miyagoe-Suzuki Y; Takeda S
    J Gene Med; 2005 Feb; 7(2):237-48. PubMed ID: 15538725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downstream utrophin enhancer is required for expression of utrophin in skeletal muscle.
    Tanihata J; Suzuki N; Miyagoe-Suzuki Y; Imaizumi K; Takeda S
    J Gene Med; 2008 Jun; 10(6):702-13. PubMed ID: 18338831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscle ERRγ mitigates Duchenne muscular dystrophy via metabolic and angiogenic reprogramming.
    Matsakas A; Yadav V; Lorca S; Narkar V
    FASEB J; 2013 Oct; 27(10):4004-16. PubMed ID: 23781095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utrophin A 5'-UTR drives cap-independent translation exclusively in skeletal muscles of transgenic mice and interacts with eEF1A2.
    Miura P; Coriati A; Bélanger G; De Repentigny Y; Lee J; Kothary R; Holcik M; Jasmin BJ
    Hum Mol Genet; 2010 Apr; 19(7):1211-20. PubMed ID: 20053670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of brain utrophin does not rescue behavioral alterations in dystrophin-deficient mice.
    Perronnet C; Chagneau C; Le Blanc P; Samson-Desvignes N; Mornet D; Laroche S; De La Porte S; Vaillend C
    Hum Mol Genet; 2012 May; 21(10):2263-76. PubMed ID: 22343141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 and neuregulin-1 as regulators of utrophin expression via the activation of NRG-1/ErbB signaling pathway in mdx cells.
    Juretić N; Díaz J; Romero F; González G; Jaimovich E; Riveros N
    Biochim Biophys Acta Mol Basis Dis; 2017 Mar; 1863(3):770-780. PubMed ID: 27988307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted inhibition of Ca2+ /calmodulin signaling exacerbates the dystrophic phenotype in mdx mouse muscle.
    Chakkalakal JV; Michel SA; Chin ER; Michel RN; Jasmin BJ
    Hum Mol Genet; 2006 May; 15(9):1423-35. PubMed ID: 16551657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arginine butyrate: a therapeutic candidate for Duchenne muscular dystrophy.
    Vianello S; Yu H; Voisin V; Haddad H; He X; Foutz AS; Sebrié C; Gillet B; Roulot M; Fougerousse F; Perronnet C; Vaillend C; Matecki S; Escolar D; Bossi L; Israël M; de la Porte S
    FASEB J; 2013 Jun; 27(6):2256-69. PubMed ID: 23430975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins.
    Tidball JG; Wehling-Henricks M
    Mol Genet Metab; 2004 Aug; 82(4):312-20. PubMed ID: 15308129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.